Business

Zelira receives $1,070,000 R&D Tax Incentive Scheme Refund

Zelira receives $1,070,000 R&D Tax Incentive Scheme Refund

Zelira Therapeutics Ltd.November 25, 20255

Zelira receives $1,070,000 R&D Tax Incentive Scheme Refund

About this update from Zelira Therapeutics Ltd.

Zelira Therapeutics Ltd has released a press release. View Attachment

View stock analysis, news, and events for Zelira Therapeutics Ltd.

More from Zelira Therapeutics Ltd.

Suspension from Official Quotation - Annual Listing Fees

August 23, 2026

Long Term Suspended Entities

July 10, 2026

All Zelira Therapeutics Ltd. news →